Search


Current filters:





Start a new search
Add filters:

Use filters to refine the search results.


Results 1-10 of 13 (Search time: 0.002 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2012Pilot trial of motivational interviewing in patients with peripheral artery diseaseQuirk, F.; Dickinson, C.; Baune, B.; Leicht, A.; Golledge, J.
2012Predictors of early and late enrollment in cardiac rehabilitation, among those referred, after acute myocardial infarctionParashar, S.; Spertus, J.A.; Tang, F.; Bishop, K.L.; Vaccarino, V.; Jackson, C.F.; Boyden, T.F.; Sperling, L.
2012Can preoperative urodynamic investigation be omitted in women with stress urinary incontinence? A non-inferiority randomized controlled trialvan Leijsen, S.; Kluivers, K.; Mol, B.; Broekhuis, S.; Milani, F.; Bongers, M.; Aalders, C.; Dietz, V.; Malmberg, G.; Vierhout, M.; Heesakkers, J.
2012Pathophysiology and natural history of anorectal sequelae following radiation therapy for carcinoma of the prostateYeoh, E.; Holloway, R.; Fraser, R.; Botten, R.; Di Matteo, A.; Butters, J.
2012Adjuvant radiotherapy versus observation alone for patients at risk of lymph-node field relapse after therapeutic lymphadenectomy for melanoma: a randomised trialBurmeister, B.; Henderson, M.; Ainslie, J.; Fisher, R.; Di Iulio, J.; Smithers, B.; Hong, A.; Shannon, K.; Scolyer, R.; Carruthers, S.; Coventry, B.; Babington, S.; Duprat, J.; Hoekstra, H.; Thompson, J.
2012Dual targeting of the epidermal growth factor receptor using the combination of cetuximab and erlotinib: Preclinical evaluation and results of the Phase II DUX Study in chemotherapy-refractory, advanced colorectal cancerWeickhardt, A.; Price, T.; Chong, G.; Gebski, V.; Pavlakis, N.; Johns, T.; Azad, A.; Skrinos, E.; Fluck, K.; Dobrovic, A.; Salemi, R.; Scott, A.; Mariadason, J.; Tebbutt, N.
2012The cost of treating advanced non-small cell lung cancer: estimates from the Chinese experienceZeng, X.; Karnon, J.; Wang, S.; Wu, B.; Wan, X.; Peng, L.; de Mello, R.A.
2012Recent peritonitis associates with mortality among patients treated with peritoneal dialysisBoudville, N.; Kemp, A.; Clayton, P.; Lim, W.; Badve, S.; Hawley, C.; McDonald, S.; Wiggins, K.; Bannister, K.; Brown, F.; Johnson, D.
2012Effects of biocompatible versus standard fluid on peritoneal dialysis outcomesJohnson, D.; Brown, F.; Clarke, M.; Boudville, N.; Elias, T.; Foo, M.; Jones, B.; Kulkarni, H.; Langham, R.; Ranganathan, D.; Schollum, J.; Suranyi, M.; Tan, S.; Voss, D.
2012Risk factors for dialysis withdrawal: An analysis of the Australia and New Zealand Dialysis and Transplant (ANZDATA) Registry, 1999-2008Chan, H.; Clayton, P.; McDonald, S.; Agar, J.; Jose, M.